Mozambique vs Myanmar: Hepatitis B surface antigen (HBsAg) prevalence
Mozambique
1.1%
in 2024
Myanmar
1.3%
in 2024
Mozambique rank
26th
Myanmar rank
24th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Mozambique
- Myanmar
How they compare
Myanmar currently reports 1.3% against 1.1% in Mozambique, a difference of 0.2%.
That makes Myanmar's figure about 1.2 times Mozambique's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Mozambique ahead.
Mozambique ranks 26th and Myanmar ranks 24th of 194 countries.
Across the 2 decades both report, Mozambique averaged higher in 1 and Myanmar in 1.
Head to head by decade
| Decade | Mozambique | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.3% | 0.2% | Mozambique |
| 2020s | 1.0% | 1.1% | 0.1% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Mozambique or Myanmar?
- Myanmar, at 1.3% against 1.1% in Mozambique as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Mozambique and Myanmar?
- 0.2%, with Myanmar ahead.
- How many years of comparable data are there for Mozambique and Myanmar?
- 10 years are reported by both, from 2015 to 2024.
- How do Mozambique and Myanmar rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Mozambique ranks 26th and Myanmar ranks 24th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.